— Know what they know.
Not Investment Advice

NVRO NYSE

Nevro Corp.
1W: -0.2% 1M: +1.9% 3M: +57.0% 1Y: -56.2% 3Y: -91.3% 5Y: -93.5%
$5.84
Last traded 2025-04-02 — delisted
NYSE · Healthcare · Medical - Devices · $224.1M mcap · 34M float · 3.80% daily turnover · Short 35% of daily vol

Balance Sheet Trends

Total Assets
$554M -12.9% ▼
5Y CAGR: +3.4%
Total Liabilities
$323M -5.8% ▼
5Y CAGR: +5.0%
Shareholders Equity
$231M -21.2% ▼
5Y CAGR: +1.3%
Cash & Investments
$293M -9.4% ▼
5Y CAGR: +4.2%
Total Debt
$251M +13.2% ▲
5Y CAGR: +6.4%
Net Debt
$157M +33.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$45M$35M$120M$104M$95M
Short-Term Investments$543M$327M$254M$219M$198M
Cash & ST Investments$588M$362M$374M$323M$293M
Net Receivables$78M$70M$79M$79M$72M
Inventory$83M$94M$100M$119M$103M
Other Current Assets$4M$0$10M$10M$8M
Total Current Assets$753M$531M$563M$531M$476M
Property, Plant & Equip.$32M$38M$36M$34M$48M
Goodwill & Intangibles$0$0$0$66M$24M
Long-Term Investments$606K$606K$606K$0$0
Other Non-Current Assets$4M$4M$3M$6M$6M
Total Non-Current Assets$36M$43M$39M$105M$78M
Total Assets$789M$575M$602M$636M$554M
— Liabilities —
Accounts Payable$23M$32M$27M$23M$24M
Short-Term Debt$169M$0$0$0$38M
Deferred Revenue$43M-$5M-$5M$0$0
Other Current Liabilities$12M$15M$12M$23M$4M
Total Current Liabilities$239M$82M$79M$83M$103M
Long-Term Debt$142M$151M$187M$211M$213M
Other Non-Current Liab.$3M$22M$2M$43M$7M
Total Non-Current Liabilities$162M$189M$199M$259M$220M
Total Liabilities$401M$271M$279M$343M$323M
— Equity —
Common Stock$35K$35K$35K$36K$38K
Retained Earnings-$493M-$624M-$607M-$699M-$813M
Accumulated OCI$598K-$364K-$3M-$243K-$1M
Total Stockholders Equity$388M$304M$324M$293M$231M
Total Liabilities & Equity$789M$575M$602M$636M$554M
— Key Metrics —
Total Debt$327M$167M$197M$222M$251M
Net Debt$283M$132M$77M$118M$157M
Total Investments$543M$327M$254M$219M$198M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms